The life science instrumentation market comprises instruments, reagents, and consumables used by pharmaceutical and biotechnology companies, academic and research institutes, and clinical research laboratories. Advancements in automation, microfluidics, and analytics are increasing the application of life science instrumentation. Life science instrumentation is commonly used in applications such as genomics, proteomics, diagnostics, and analytical instrumentation.

Key Takeaways

Key players operating in the life science instrumentation are Agilent Technologies, Danaher Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., Bruker Corporation, Waters Corporation, GE Healthcare, Shimadzu Corporation, PerkinElmer Inc., Illumina, Inc., Qiagen N.V., Merck KGaA, Abbott Laboratories, Hitachi High-Technologies Corporation, Roche Diagnostics, Beckman Coulter, Inc., and Eppendorf AG.

The key opportunities in the Life Science Instrumentation Market Growth include rising focus on stem cell and cancer research, growing need for personalized medicine, and increasing mergers and acquisitions by key players to expand their offerings. Advancements in microscopy, flow cytometry, next-generation sequencing, and laboratory automation are fueling the growth of life science instrumentation market.

Market drivers

Rising government investments and funding for life science research is fueling the adoption of advanced life science instrumentation. Growing R&D expenditure by pharmaceutical and biotechnology companies for development of biologics and biosimilars is also driving the demand for analytical instruments. In addition, increasing prevalence of chronic and infectious diseases worldwide is propelling the clinical diagnostics market, thereby augmenting the life science instrumentation market growth over the forecast period.

Get more insights on Life Science Instrumentation Market